Authors

Robert S. Fisher, MD
Latest Article

What’s in a Name? The Seizure Classification Update and What It All Means

The conventional classification of seizure types needed a makeover. To employ the 2017 ILAE classification, a clinician should follow some general rules.

Roocha Patel, MD
Latest Article

Loss of Consciousness in an Elderly Woman With Prior CVA: What Cause?

Here, view results of CT of the head and axial FLAIR and axial diffusion-weighted MRI studies. What is in your differential? What is your diagnosis?

Sam Adler, MD
Latest Article

Psychosis in Parkinson Disease

A host of neuropsychiatric disorders are intrinsic to Parkinson disease or occur as a complication of the dopaminergic therapies. Here's what to look for.

Samuel Pleasure, MD, PhD
Latest Article

Narcolepsy and the Flu

Observations over the last few years have indicated that an inciting event of narcolepsy may be infection with influenza or vaccination with particular influenza vaccines.

Sergio Fantini, PhD
Latest Article

A New Tool to Assess Brain Vascular Health

Noninvasive measurements of cerebral hemodynamics and oxygenation can have a significant impact on the assessment of cerebrovascular conditions and can monitor the effects of clinical procedures on brain circulation.

Sreeram Ramagopalan, PhD
Latest Article

3 New Findings on Epilepsy

ADHD lowers the quality of life in adults with epilepsy; epilepsy is associated with social deprivation and increased risk of venous thromboembolism: details of these recent findings in this slide show.

Steven A. King, MD, MS
Latest Article

Headache: A Pop Quiz

Test your headache IQ here.

Susan Kweskin
Latest Article

CGRPs: New Help in Migraine Prophylaxis?

A new class of injectable monoclonal antibodies directed against calcitonin gene related peptide (CGRP) or its receptor may offer hope to migraineurs who have not found effective prophylactic therapy.

Taya Varteresian DO, MS
Latest Article

9 Natural Supplements for Cognitive Impairment

Which vitamins and supplements have shown promise in treating dementia and preventing cognitive decline?

Theodore Henderson, MD, PhD
Latest Article

Idiopathic Parkinson: Diagnosis of the Deceptive

The emergence of Ioflupane I 123 Injection (DaTSCAN) provides clinicians with helpful information to differentiate idiopathic Parkinson disease from other diseases.

Thomas P. Bravo, MD
Latest Article

PACAP: Lessons From A Potent Migraine Inducer?

PACAP38 is a potent aggravator of migraine, a new study shows. This provides several new potential therapeutic targets -- most prominently a specific PACAP receptor PAC1.

Todd J. Schwedt, MD
Latest Article

Poor Acute Treatment May Lead to Chronic Migraine

Efficacy of acute medication matters beyond just treating a single migraine. It may increase the risk of worsened disease.

Veronica Hackenthal, MD
Latest Article

New Type of Chronic Daily Headache in Older Women?

This case series appears to identify a new subtype of chronic daily headache in overweight/obese women in their fifties and sixties.

Veronica Hackethal MD
Latest Article

Probing Headaches: A Diagnostic Challenge Quiz

What differentiates migraine from underlying intracranial pathology that may require neuroimaging, like tumors, abscesses, aneurysms, or hemorrhages? Test your skills with this 5-question quiz.

Veronica Hackethal, MD
Latest Article

Chronic Migraine Out of Control Despite Multiple Drug Trials

Your patient asks if a ketogenic diet can reduce her migraines. What will you tell her?

Yuebing Li, MD
Latest Article

Finding Consensus: Treating Myasthenia Gravis

The author discusses MG disease classifications as well as treatment goals and treatment adherence.

Dilan Athauda, MBBS, MRCP, BSc
Latest Article

Exenatide for Parkinson Symptoms: Early Results Are Positive

Exenatide, a GLP-1 agonist, has been shown to protect neurons. The authors of two small studies of this agent's effects on motor function in Parkinson disease discuss the evidence here.

Pradeep N. Modur, MD, MS
Latest Article

Leveraging Technology to Improve Epilepsy Treatment: Responsive Neurostimulation

An update on responsive neurostimulation, the only implantable, closed-loop device approved for treating seizures.

Thomas Foltynie, PhD, MD
Latest Article

Exenatide for Parkinson Symptoms: Early Results Are Positive

Exenatide, a GLP-1 agonist, has been shown to protect neurons. The authors of two small studies of this agent's effects on motor function in Parkinson disease discuss the evidence here.

Amy Kao, MD
Latest Article

Dietary Therapy to Improve Epilepsy Outcomes: Case Vignettes

The authors present illustrative fictional accounts of patients with medical problems with co-occurring epilepsy.

Brittany Cines, RD, LD, CNSC, CSP
Latest Article

Dietary Therapy to Improve Epilepsy Outcomes: Case Vignettes

The authors present illustrative fictional accounts of patients with medical problems with co-occurring epilepsy.

Amit Ban
Latest Article

Case Study: Siblings With Hypotonia in All Limbs

Two young siblings presented to the pediatric department with mental retardation, developmental delay, ataxia, and nystagmus since birth. What's your diagnosis after reviewing the case?

Shawn Marshall, MD, MSc
Latest Article

Eight Key Features of Post-Concussion Care

It is often unclear which treatments are most appropriate for the constellation of concussion symptoms. Thus, evidence-based education as well as treatment and management options to facilitate recovery are required.

Heather Zwickey, PhD
Latest Article

6 Essential Nutrition Recommendations for Parkinson Disease

This article provides some straightforward nutritional recommendations that neurologists can share with their patients.

Kathleen M. Shannon, MD, FAAN, FANA
Latest Article

The Gut Has It: Microbes and Parkinson

While it is premature to conclude that changes in intestinal microbes influence the genesis or progression of PD, preliminary evidence indicates that they may be associated with inflammation in the intestinal wall.

David Y. Hwang, MD
Latest Article

Top Issues in Emergency Neurology Today

Neurology on the front lines engages patients and their families in a shared decision-making process regarding goals of care.

Tracy T. Batchelor, MD
Latest Article

Neurocognitive Outcomes in Primary CNS Lymphoma: Clinical Implications

Primary central nervous system lymphoma (PCNSL) is a rare but aggressive malignancy that accounts for approximately 3% of all primary CNS cancer. New studies have changed the landscape of PCNSL treatment paradigms and expectations for outcome.

Michael W. Parsons, PhD
Latest Article

Neurocognitive Outcomes in Primary CNS Lymphoma: Clinical Implications

Primary central nervous system lymphoma (PCNSL) is a rare but aggressive malignancy that accounts for approximately 3% of all primary CNS cancer. New studies have changed the landscape of PCNSL treatment paradigms and expectations for outcome.

Kasra Maasumi, MD, MS
Latest Article

Treating Menstrual Migraines

Given the severity and treatment resistance of menstrual migraine, clinicians should watch for the signs and symptoms discussed in this case.

Patrick W. Hullett, MD, PhD
Latest Article

Treating Menstrual Migraines

Given the severity and treatment resistance of menstrual migraine, clinicians should watch for the signs and symptoms discussed in this case.
Contact Info

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512

609-716-7777

HCP Live
Brand Logo

© 2025 MJH Life Sciences®

All rights reserved.

Home
About Us
News
Contact Us